 |
|
Inhibition of Adrenergic Function in the Treatment of Hypertension
Edward D. Frohlich, MD
Arch Intern Med. 1974;133(6):1033-1048.
Abstract
With the availability of effective antihypertensive drugs, it has become possible to reduce significantly the morbidity and mortality from cardiovascular complications of hypertension. Among the more potent agents that maintain a reduced arterial blood pressure are those that inhibit sympathetic activity; this inhibition may be achieved at practically any anatomical level of adrenergic function. However, for these compounds to maintain and enhance their effectiveness, they must be used in conjunction with diuretics. The following discussion reviews each of these adrenolytic agents, describing their respective mechanisms of action, hemodynamic effects, their clinical uses, and side effects.
Author Affiliations
Oklahoma City
From the University of Oklahoma Health Sciences Center, Oklahoma City.
Footnotes
Received for publication Oct 23,1973; accepted Jan 28, 1974.
Reprint requests to Box 26901, Oklahoma City, OK 73190 (Dr. Frohlich).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Mechanisms Contributing to High Blood Pressure
FROHLICH
ANN INTERN MED 1983;98:709-714.
ABSTRACT
Methyldopa
Frohlich
Arch Intern Med 1980;140:954-959.
ABSTRACT
Medical Management of Hypertension
Hutchinson
ANGIOLOGY 1979;30:558-567.
|
